Danggui Ginseng (Panax ginseng 'Danggui')

Danggui Ginseng is a cultivated variety of Panax ginseng containing ginsenosides Rg1 and Rb1, the primary saponins believed to modulate adrenal cortisol output and support HPA-axis adaptation. Analytical studies have confirmed its ginsenoside profile, though no human clinical trials have evaluated its efficacy or safety as a distinct supplement.

Origin & History

Danggui Ginseng (Panax ginseng 'Danggui') does not appear as a recognized cultivar variant in scientific literature; standard Panax ginseng is a perennial plant from the Araliaceae family cultivated in Korea and China, with roots harvested at 4-6 years. The roots are processed using water-ethanol extraction (20:80 ratio), high hydrostatic pressure with enzymes at 100 MPa, or hot water reflux at 80-90°C to extract triterpene saponins known as ginsenosides.

Historical & Cultural Context

Panax ginseng roots have been used in Traditional Chinese Medicine and Korean medicine for centuries as an adaptogen for vitality. Modern cultivation occurs in regions including Geumsan and Punggi, Korea, though specific historical duration and traditional indications are not quantified in available research.

Health Benefits

• No clinical health benefits documented - no human trials, RCTs, or meta-analyses found in available research
• Traditional use suggests adaptogenic properties for vitality - evidence quality: Traditional only
• Ginsenoside content (Rg1 and Rb1) identified through analytical methods - evidence quality: Laboratory analysis only
• Extraction methods optimize bioactive compound yield - evidence quality: In-vitro processing studies only
• No specific therapeutic effects validated through clinical research

How It Works

Ginsenoside Rg1 is thought to bind glucocorticoid receptors and modulate HPA-axis signaling, potentially attenuating cortisol hypersecretion under stress conditions. Ginsenoside Rb1 may interact with GABA-A receptors and inhibit monoamine oxidase activity, contributing to reported anxiolytic and neuroprotective effects observed in preclinical models. These mechanisms are extrapolated from broader Panax ginseng research, as no mechanism-specific studies exist for the Danggui cultivar itself.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were identified in the research for either Panax ginseng 'Danggui' or standard Panax ginseng. The available research focuses solely on extraction optimization methods and analytical confirmation of ginsenosides via HPLC/MS/MS, without any clinical outcome data or PubMed citations.

Clinical Summary

No human clinical trials, randomized controlled trials, or meta-analyses have been conducted specifically on Danggui Ginseng as a distinct cultivar. Available evidence is limited to analytical chemistry confirming the presence of ginsenosides Rg1 and Rb1, and to traditional ethnobotanical records describing adaptogenic and vitality-supporting uses. Broader Panax ginseng research — including small RCTs with 30–100 participants — has shown modest effects on fatigue and cognitive function, but these findings cannot be directly attributed to this specific cultivar. The overall evidence quality for Danggui Ginseng specifically is rated as traditional use only.

Nutritional Profile

Danggui Ginseng (Panax ginseng 'Danggui') is a cultivar variant of Panax ginseng with a nutritional and phytochemical profile largely consistent with standard Panax ginseng root, though cultivar-specific concentration data remains limited. Macronutrient composition per 100g dried root (extrapolated from Panax ginseng general data): carbohydrates 60-70g (predominantly polysaccharides and starches), protein 10-15g (including peptides and amino acids such as arginine, glutamic acid, and aspartic acid), fat 1-2g, dietary fiber 10-15g. Moisture content in fresh root approximately 70-75%. Key bioactive compounds: ginsenosides (saponins) identified analytically include Rg1 (typically 0.1-0.5% dry weight in standard Panax ginseng) and Rb1 (typically 0.2-0.8% dry weight), with total ginsenoside content in Panax ginseng cultivars generally ranging 2-4% dry weight; cultivar-specific concentrations for 'Danggui' not precisely established in published literature. Polysaccharides (ginsenans) present at approximately 10-20% dry weight, contributing immunomodulatory potential in related cultivars. Polyacetylenes (panaxynol, panaxydol) present at trace levels (<0.1% dry weight). Micronutrients include potassium (approximately 400-600mg/100g dry weight), calcium (60-100mg/100g), magnesium (40-60mg/100g), iron (3-5mg/100g), zinc (1-2mg/100g), manganese (1-3mg/100g), and phosphorus (150-250mg/100g), based on Panax ginseng reference data. B vitamins present in minor quantities including thiamine, riboflavin, and niacin at <1mg/100g each. Volatile oils and phytosterols present at trace levels. Bioavailability notes: ginsenoside bioavailability from raw root is low (~5-10%) due to molecular size and poor intestinal absorption; gut microbiota convert protopanaxadiol ginsenosides (e.g., Rb1) to more bioavailable compound K; standardized extracts and optimized extraction methods (ethanol or water-ethanol mixtures) significantly enhance ginsenoside yield and bioavailability compared to raw root consumption. Polysaccharide bioactivity is route-dependent, with greater effect noted via direct gastrointestinal exposure.

Preparation & Dosage

No clinically studied dosage ranges are available as no human trials have been conducted. Extraction studies optimize for ginsenosides Rg1 and Rb1 content but do not specify therapeutic doses or standardization levels. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research to determine synergistic ingredients

Safety & Interactions

Because Danggui Ginseng shares its primary ginsenoside profile with Panax ginseng, similar precautions are generally applied: side effects such as insomnia, headache, and gastrointestinal upset have been reported with standard Panax ginseng use at doses of 200–400 mg daily. Ginsenosides may potentiate anticoagulant medications including warfarin, and may exhibit mild estrogenic activity warranting caution in hormone-sensitive conditions. Use during pregnancy and breastfeeding is not recommended due to insufficient safety data for this cultivar specifically. Individuals taking antidiabetic drugs or MAO inhibitors should consult a healthcare provider before use due to potential pharmacodynamic interactions.